Search by Drug Name or NDC
NDC 60219-1748-02 Atropine 10 mg/mL Details
Atropine 10 mg/mL
Atropine is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is ATROPINE SULFATE.
MedlinePlus Drug Summary
Ophthalmic atropine is used before eye examinations to dilate (open) the pupil, the black part of the eye through which you see. It is also used to relieve pain caused by swelling and inflammation of the eye.
Related Packages: 60219-1748-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Atropine Ophthalmic
Product Information
| NDC | 60219-1748 |
|---|---|
| Product ID | 60219-1748_2af4941e-cde9-42d7-8594-e92cf960f307 |
| Associated GPIs | |
| GCN Sequence Number | 007866 |
| GCN Sequence Number Description | atropine sulfate DROPS 1 % OPHTHALMIC |
| HIC3 | Q6J |
| HIC3 Description | MYDRIATICS |
| GCN | 32952 |
| HICL Sequence Number | 002004 |
| HICL Sequence Number Description | ATROPINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Atropine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Atropine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | ATROPINE SULFATE |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214752 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60219-1748-02 (60219174802)
| NDC Package Code | 60219-1748-2 |
|---|---|
| Billing NDC | 60219174802 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (60219-1748-2) / 2 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2022-07-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 15.1025 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | ATROPINE 1% EYE DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis